# Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy

> **NCT07521384** · — · ENROLLING_BY_INVITATION · sponsor: **Healing Hope International** · enrollment: 36 (estimated)

## Conditions studied

- Traumatic Brain Injury
- Cerebral Palsy
- Hypoxic Ischemic Encephalopathy
- Neurologic Disorders
- MS (Multiple Sclerosis)
- Alzheimer Dementia (AD)
- Parkinson Disease (PD)
- Stroke
- Autism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07521384
- **Lead sponsor:** Healing Hope International
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-06-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2029-01-30
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07521384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07521384, "Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07521384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*